Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Daiichi Sankyo
Fuji
Johnson and Johnson
Teva
Medtronic
Queensland Health
US Army
Deloitte

Generated: May 23, 2018

DrugPatentWatch Database Preview

NATRECOR Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Natrecor, and when can generic versions of Natrecor launch?

Natrecor is a drug marketed by Scios Llc and is included in one NDA.

The generic ingredient in NATRECOR is nesiritide recombinant. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the nesiritide recombinant profile page.
Drug patent expirations by year for NATRECOR
Pharmacology for NATRECOR

US Patents and Regulatory Information for NATRECOR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Scios Llc NATRECOR nesiritide recombinant FOR SOLUTION;INTRAVENOUS 020920-001 Aug 10, 2001 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

Expired US Patents for NATRECOR

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Scios Llc NATRECOR nesiritide recombinant FOR SOLUTION;INTRAVENOUS 020920-001 Aug 10, 2001 ➤ Try a Free Trial ➤ Try a Free Trial
Scios Llc NATRECOR nesiritide recombinant FOR SOLUTION;INTRAVENOUS 020920-001 Aug 10, 2001 ➤ Try a Free Trial ➤ Try a Free Trial
Scios Llc NATRECOR nesiritide recombinant FOR SOLUTION;INTRAVENOUS 020920-001 Aug 10, 2001 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Chubb
US Department of Justice
Moodys
Covington
Mallinckrodt
Chinese Patent Office
Julphar
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.